Guanfacine Use in the ICU for Management of Sedation Weaning
Clinical Drug Investigation · 2025
DOI: 10.1007/s40261-025-01434-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Drug Investigation, 2025. Verfasst von Young R Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Ben and Maytee Fisch College of Pharmacy, The University of Texas at Tyler, 3900 University Blvd, Tyler, TX, 75799, …. Hauptthemen laut MEDLINE: Guanfacine, Hypnotics and Sedatives, Adrenergic alpha-2 Receptor Agonists, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Themen: Beatmung und Weaning
Abstract (Originalsprache)
Recent evidence highlights the increasing utilization of guanfacine in the intensive care unit. While dexmedetomidine is a widely used sedative and anti-anxiety agent in the intensive care unit, prolonged use can lead to withdrawal effects when attempting to reduce the dosage. This has generated interest in using guanfacine to manage agitation in patients being weaned off dexmedetomidine. Clonidine has been used for dexmedetomidine weaning, but its use has been associated with adverse cardiovascular events. Some observational studies and case reports have explored the use of guanfacine and have shown its benefits and tolerability for patients taking dexmedetomidine experiencing adverse effects. Guanfacine is increasingly being used in the intensive care unit instead of clonidine and is commonly prescribed for the management of withdrawal effects. While there are limited data from observational studies, it holds promise for future clinical research and broader adoption of guanfacine in the intensive care unit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Ben and Maytee Fisch College of Pharmacy, The University of Texas at Tyler, 3900 University Blvd, Tyler, TX, 75799, USA. younglee@uttyler.edu.
- Department of Clinical Sciences, Ben and Maytee Fisch College of Pharmacy, The University of Texas at Tyler, 3900 University Blvd, Tyler, TX, 75799, USA.
Zitieren
APA
Lee, Y. R., Garza, A., & Kiama, L. (2025). Guanfacine Use in the ICU for Management of Sedation Weaning. Clinical Drug Investigation. https://doi.org/10.1007/s40261-025-01434-x
Vancouver
Lee YR, Garza A, Kiama L. Guanfacine Use in the ICU for Management of Sedation Weaning. Clinical Drug Investigation. 2025. doi:10.1007/s40261-025-01434-x
BibTeX
@article{Lee2025,
author = {Lee, Young R and Garza, Alayna and Kiama, Laureen},
title = {Guanfacine Use in the ICU for Management of Sedation Weaning},
journal = {Clinical Drug Investigation},
year = {2025},
doi = {10.1007/s40261-025-01434-x}
}
EUVIMED